When: 11 - 13 February 2025
Where: TOPRA Office, 3rd Floor City Reach, 5-6 Greenwich View Place, London, E14 9NN, UK
Day 1 start time: TBC GMT| Day 3 end time: TBC GMT

Also available as an online course, please click here for the online registration option

Course Overview

This Masterclass is designed for regulatory affairs professionals to develop and deepen their understanding of all aspects of the nonclinical development for a new active substance including:

• The nonclinical regulatory requirements for drug development
• Modern approaches to nonclinical regulatory requirements for drug development including considerations for candidate selection and the latest requirements for pharmacokinetics and toxicology, genotoxicity, carcinogenicity and reproduction testing
• The role of regulatory affairs throughout the nonclinical phase to filing and life-cycle management
• Considerations for the nonclinical components of regulatory documents and submissions including IB, IMPD, IND, NDA, MAA and CTD reports

The use of case studies and workshops will assist in the achievement of these learning outcomes and enable students to consolidate their understanding and knowledge. 

This course gave a very good overview of the non-clinical development which is very helpful to further develop your understanding of this field of drug development.”  – 2018 delegate

Benefits to delegates

This course will enable you to:

• Develop a systematic understanding,  and a critical awareness of the practical management aspects of nonclinical development, the types and design of nonclinical safety and pharmacokinetic studies and the regulatory requirements nonclinical drug development
• Demonstrate a comprehensive understanding of the nonclinical regulatory requirements, nonclinical guidelines and other requirements for running nonclinical drug safety studies
• Have a conceptual understanding of the legal and ethical regulatory aspects of nonclinical research and the importance of critical evaluation of the study designs and data generated during research on medicinal products
• Demonstrate the ability to critically analyse the nonclinical regulatory documentation and guidelines for the nonclinical part of drug development
• Deal with complex issues both systematically and creatively, make sound judgements in the absence of complete data and communicate your conclusions to the specialist and non-specialist audiences including working with other departments
• Critically appraise and evaluate communications from regulatory bodies and research publications covering nonclinical data

Programme

The draft programme is available to download HERE

Module Leaders

• Lesley Reeve,  Senior Director, Global Regulatory Strategy, Product Development and Market Access Consulting, Fortrea
  

Presenters

Suitable for

• Students of the TOPRA MSc programme
• Delegates from the regulatory affairs industry who wish to develop their strategic planning of nonclinical development
• Delegates from allied industries who wish to have a comprehensive understanding of the subject

Pricing

Type
TOPRA MSc Student: £1650 plus VAT*
TOPRA Member: £1900 plus VAT*
Non Member: £2100 plus VAT*

* VAT, if applicable, is charged at the rate of 20%   

Discounted place

• Those working for regulatory agencies, government agencies or academic institutions
• Those working for charities, patient groups or in full-time education

A limited number of discounted places are available at the rates below. Please note that discounted places are not valid for those enrolled on the MSc course.
Please email us at meetings@topra.org for a discount code before making your booking.

Terms and conditions

By booking a place on this course you are agreeing to the training terms and conditions.